GRAL
GRAIL, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$80.34
−0.35%Margins
Gross margin
-10.8%
EBITDA margin
-249.8%
EBIT margin
-338.4%
Net margin
-236.9%
FCF margin
-178.7%
-15.4%
Return on equity
-13.8%
Return on assets
-21.2%
Return on invested capital
0.06x
Asset turnover
-$294.7M
Cash from operations
$19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026